Potent In Vivo Antiviral Activity of the Herpes Simplex Virus Primase-Helicase Inhibitor BAY 57-1293

BAY 57-1293 belongs to a new class of antiviral compounds and inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex. In various rodent models of HSV infection the antiviral activ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Betz, Ulrich A. K., Fischer, Rüdiger, Kleymann, Gerald, Hendrix, Martin, Rübsamen-Waigmann, Helga
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2002
Aiheet:
Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC127257/
https://ncbi.nlm.nih.gov/pubmed/12019088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1766-1772.2002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia